rotation.to
Following this device: dark.
Free account
rotation.to
Appearance
Following this device: dark.
Drag a card by its title · ⚙ to size, swap or remove

Who

William Valle

Director

Company insider

Files Form 4 as: Director, TriSalus Life Sciences; Director, American Oncology Network.

In numbers

Trades disclosed
13
Buys
1
Sells
0
Bought
$250K
Sold
$0
Companies
2
Companies where not an officer
2
First trade
4 May 2024
Last trade
14 May 2026
Last filed
15 May 2026

Companies traded

Everywhere else they filed: board seats, 10% stakes, other companies
TLSI TriSalus Life SciencesDirector · Medical Devices · last 14 May 20261 buy · 0 sells
American Oncology NetworkDirector · last 16 Jul 20240 buys · 0 sells

Activity over time

1 Feb – 1 Oct
01Feb 26Apr 26Jun 26Aug 26Oct 26

Buys above the line, sells below, each month.

Every trade

TradedCompanyWhatAmount
14 May 2026filed 15 May 2026TLSI TriSalus Life SciencesMedical DevicesSEC FORM 4 Code A—28,201 at $0.00filing
14 May 2026filed 15 May 2026TLSI TriSalus Life SciencesMedical DevicesSEC FORM 4 Code A—24,553 at $0.00filing
14 May 2026filed 15 May 2026TLSI TriSalus Life Sciencesoption or derivative · Medical DevicesSEC FORM 4 Code A—56,403 at $0.00filing
14 May 2026filed 15 May 2026TLSI TriSalus Life Sciencesoption or derivative · Medical DevicesSEC FORM 4 Code A—56,403 at $0.00filing
14 May 2026filed 15 May 2026TLSI TriSalus Life SciencesMedical DevicesSEC FORM 4 Code A—28,201 at $0.00filing
14 May 2026filed 15 May 2026TLSI TriSalus Life SciencesMedical DevicesSEC FORM 4 Code A—24,553 at $0.00filing
23 Feb 2026filed 23 Feb 2026TLSI TriSalus Life SciencesMedical DevicesSEC FORM 4 Bought$125K30,487 at $4.10filing
23 Feb 2026filed 23 Feb 2026TLSI TriSalus Life SciencesMedical DevicesSEC FORM 4 Bought$125K30,487 at $4.10filing
12 Jun 2025filed 27 Jun 2025TLSI TriSalus Life Sciencesoption or derivative · Medical DevicesSEC FORM 4 Code A—15,000 at $0.00filing
29 Jan 2025filed 31 Jan 2025TLSI TriSalus Life Sciencesoption or derivative · Medical DevicesSEC FORM 4 Code A—35,000 at $0.00filing
29 Jan 2025filed 31 Jan 2025TLSI TriSalus Life Sciencesoption or derivative · Medical DevicesSEC FORM 4 Code A—6,250 at $0.00filing
16 Jul 2024filed 18 Jul 2024American Oncology NetworkSEC FORM 4 Code A—5,000 at $0.00filing
4 May 2024filed 7 May 2024American Oncology NetworkSEC FORM 4 Code A—14,981 at $0.00filing

Sectors

Health Care1

Buys in green, sells in red, by the company’s sector.

Related people

Richard MarshakChief Commercial Officer · Chief Commercial Officer at TriSalus Life Sciences, filing Form 4 there in the last year
Mary T. SzelaCEO and President · CEO and President at TriSalus Life Sciences, filing Form 4 there in the last year
Jennifer StevensChief Regulatory Officer · Chief Regulatory Officer at TriSalus Life Sciences, filing Form 4 there in the last year
Bryan F. CoxChief of Research · Chief of Research at TriSalus Life Sciences, filing Form 4 there in the last year
David PatienceChief Financial Officer · Chief Financial Officer at TriSalus Life Sciences, filing Form 4 there in the last year